Leerink Swann Reiterates “Outperform” Rating for Acadia Healthcare Co. (ACHC)
Acadia Healthcare Co. (NASDAQ:ACHC)‘s stock had its “outperform” rating restated by stock analysts at Leerink Swann in a research note issued to investors on Monday. They currently have a $80.00 price objective on the stock. Leerink Swann’s price target would suggest a potential upside of 66.11% from the stock’s current price.
A number of other equities analysts have also recently commented on the stock. Royal Bank Of Canada dropped their price target on shares of Acadia Healthcare from $86.00 to $78.00 and set an “outperform” rating for the company in a research note on Monday, August 1st. Jefferies Group reaffirmed a “buy” rating and set a $85.00 price target on shares of Acadia Healthcare in a research note on Monday, June 27th. RBC Capital Markets reaffirmed an “outperform” rating and set a $78.00 price target (down from $86.00) on shares of Acadia Healthcare in a research note on Monday, August 1st. Robert W. Baird dropped their price target on shares of Acadia Healthcare from $67.00 to $66.00 and set an “outperform” rating for the company in a research note on Thursday, September 15th. Finally, Zacks Investment Research cut shares of Acadia Healthcare from a “hold” rating to a “sell” rating in a research note on Monday, July 11th. One equities research analyst has rated the stock with a sell rating, one has given a hold rating and twelve have issued a buy rating to the company’s stock. Acadia Healthcare has an average rating of “Buy” and an average price target of $77.21.
Shares of Acadia Healthcare (NASDAQ:ACHC) opened at 48.16 on Monday. The firm has a 50-day moving average of $51.24 and a 200-day moving average of $55.28. Acadia Healthcare has a one year low of $47.51 and a one year high of $74.77. The stock has a market cap of $4.21 billion, a PE ratio of 25.73 and a beta of 0.84.
Acadia Healthcare (NASDAQ:ACHC) last released its quarterly earnings results on Friday, July 29th. The company reported $0.73 EPS for the quarter, hitting analysts’ consensus estimates of $0.73. Acadia Healthcare had a net margin of 6.44% and a return on equity of 9.35%. The firm earned $756.50 million during the quarter, compared to analysts’ expectations of $752.57 million. During the same period in the previous year, the company earned $0.57 EPS. The firm’s revenue for the quarter was up 66.8% compared to the same quarter last year. On average, equities research analysts expect that Acadia Healthcare will post $2.64 earnings per share for the current fiscal year.
In other news, major shareholder Waud Capital Partners Iii, L.L sold 457,443 shares of the business’s stock in a transaction dated Friday, September 16th. The shares were sold at an average price of $48.39, for a total value of $22,135,666.77. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, COO Ronald Morgan Fincher sold 8,800 shares of the business’s stock in a transaction dated Monday, August 8th. The shares were sold at an average price of $52.56, for a total transaction of $462,528.00. Following the completion of the sale, the chief operating officer now owns 120,780 shares of the company’s stock, valued at approximately $6,348,196.80. The disclosure for this sale can be found here. 17.20% of the stock is currently owned by insiders.
Large investors have recently bought and sold shares of the stock. American International Group Inc. raised its position in Acadia Healthcare by 71.7% in the second quarter. American International Group Inc. now owns 2,218 shares of the company’s stock valued at $123,000 after buying an additional 926 shares during the period. Advisor Group Inc. purchased a new position in Acadia Healthcare during the second quarter valued at approximately $166,000. Springbok Capital Management LLC raised its position in Acadia Healthcare by 101.3% in the first quarter. Springbok Capital Management LLC now owns 3,741 shares of the company’s stock valued at $206,000 after buying an additional 1,883 shares during the period. Jane Street Group LLC purchased a new position in Acadia Healthcare during the second quarter valued at approximately $210,000. Finally, Calvert Investment Management Inc. raised its position in Acadia Healthcare by 0.9% in the second quarter. Calvert Investment Management Inc. now owns 4,192 shares of the company’s stock valued at $232,000 after buying an additional 39 shares during the period.
Acadia Healthcare Company Profile
Acadia Healthcare Company, Inc is a provider of behavioral healthcare services. The Company operates in two segments: U.S. Facilities and U.K. Facilities. The Company develops and operates inpatient psychiatric facilities, residential treatment centers, group homes, substance abuse facilities and facilities providing outpatient behavioral healthcare services to serve the behavioral health and recovery needs of communities throughout the United States, the United Kingdom and Puerto Rico.
Receive News & Stock Ratings for Acadia Healthcare Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare Co. and related stocks with our FREE daily email newsletter.